Diacomit
Active Ingredient(s): StiripentolFDA Approved: * August 20, 2018
Pharm Company: * BIOCODEX SA
Category: Anticonvulsant
Stiripentol, sold under the brand name Diacomit, is an anticonvulsant medication used for the treatment of Dravet syndrome - a serious genetic brain disorder.[5][6] The most common side effects include loss of appetite, weight loss, insomnia (difficulty sleeping), drowsiness, ataxia (inability to coordinate muscle movements), hypotonia (low muscle strength) and dystonia (muscle disorders).[5] Contents 1 Medical uses 2 Contraindications 3 Adver... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.